Department of Internal Medicine, Division of Endocrinology and Metabolism, Medical University of Graz, Auenbruggerplatz 15, A-8036 Graz, Austria.
Eur Heart J. 2011 Nov;32(21):2642-9. doi: 10.1093/eurheartj/ehr150. Epub 2011 May 23.
Renin is the key regulator of the renin-angiotensin-aldosterone system. Previous studies have reported conflicting results on the relation of plasma renin with fatal cardiovascular events. This study in a large cohort of patients sought to evaluate the association between plasma renin concentration (PRC) and cardiovascular mortality after long-term follow-up of almost 10 years.
Plasma renin concentration [median: 11.4 (6.0-24.6) pg/mL] was measured in 3303 patients (mean age: 62.7 ± 10.6 years; 30.3% women) referred to coronary angiography. After a median follow-up of 9.9 years, 554 participants (16.8%) with PRC measurement at baseline had died due to fatal cardiovascular events. Multivariable-adjusted Cox analysis revealed that when compared with participants in the lowest PRC quartile, those in the highest quartile were at increased risk of cardiovascular mortality (hazard ratio: 1.79, 95% CI 1.28-2.48). Analyses of specific causes of cardiovascular death showed that for each standard deviation increase in log-PRC there was a 22% (P = 0.006) increase in risk of sudden cardiac death and a 23% (P = 0.033) greater risk of death due to heart failure. The association of PRC with cardiovascular mortality remained stable after adjustment for established cardiovascular risk factors, ongoing antihypertensive medication, immunoreactive angiotensin II, and aldosterone levels. Age, N-terminal pro-B-type natriuretic peptide levels, coronary artery disease, the use of angiotensin-converting enzyme-inhibitors, beta-blockers, diuretics, and kidney function were important effect modifiers.
Plasma renin concentration is associated with long-term cardiovascular mortality in patients referred to coronary angiography. Further intervention studies should determine whether renin is a potential therapeutic target or only a marker of mortality risk in various cardiovascular risk groups.
肾素是肾素-血管紧张素-醛固酮系统的关键调节剂。先前的研究报告了血浆肾素与致命心血管事件之间关系的相互矛盾的结果。本研究在一个大型患者队列中,旨在评估近 10 年的长期随访后,血浆肾素浓度(PRC)与心血管死亡率之间的关系。
在 3303 名(平均年龄:62.7 ± 10.6 岁;30.3%为女性)接受冠状动脉造影检查的患者中测量了血浆肾素浓度[中位数:11.4(6.0-24.6)pg/mL]。在中位随访 9.9 年后,554 名(16.8%)基线时测量 PRC 的参与者死于致命心血管事件。多变量调整的 Cox 分析显示,与 PRC 最低四分位数的参与者相比,PRC 最高四分位数的参与者发生心血管死亡率的风险增加(风险比:1.79,95%CI 1.28-2.48)。对心血管死亡的具体原因的分析表明,对于每个标准偏差的 log-PRC 增加,心源性猝死的风险增加 22%(P = 0.006),心力衰竭导致的死亡风险增加 23%(P = 0.033)。在调整既定心血管危险因素、持续抗高血压药物、免疫反应性血管紧张素 II 和醛固酮水平后,PRC 与心血管死亡率的相关性仍然稳定。年龄、氨基末端 pro-B 型利钠肽水平、冠心病、血管紧张素转换酶抑制剂、β受体阻滞剂、利尿剂和肾功能是重要的效应修饰因子。
在接受冠状动脉造影检查的患者中,血浆肾素浓度与长期心血管死亡率相关。进一步的干预研究应确定肾素是否是各种心血管风险人群中潜在的治疗靶点或仅为死亡率风险的标志物。